YEMANJA CANCER CARE INITIATIVE INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

Oluwatoyin Shonukan

Phone

4013147385

Tax Period

2022-01-01 to 2022-12-31

YEMANJA CANCER CARE INITIATIVE INC, founded in 2020, is a micro nonprofit in the Diseases & Disorders sector that reported $37K in total revenue in fiscal year 2022. Revenue fell 151% from the prior year — a significant decline worth monitoring.

Mission

To reduce disparities in cancer care in underserved populations through health education, early detection, improvement in access to cancer care and scientific research.

Program Service Accomplishments

Program 1

Expenses: $6,382 Revenue: $0

Yemanja Cancer Care Initiative partnered with local health care providers and nurses to carry out an ongoing community awareness and education campaign, highlighting the importance of early detection and early diagnosis for improving outcomes from breast and cervical cancer. There is a continuous outreach to community leaders, women's professional groups including hairdressers, dressmakers and market women and leaders and members of all religious organizations.

Program 2

Expenses: $28,773 Revenue: $0

Yemanja Cancer Care Initiative initiated a cervical cancer screening program in a small local government area near Lagos, the economic capital of Nigeria. Two thousand two hundred women were screened for cervical pre-cancer using a combined one-day screen and treat approach. Women who were confirmed to have lesions compatible with cervical pre-cancer were treated with thermal coagulation. The women are encouraged to return after 12 months for re-screening. In 2022, we screened 2,200 women, and are well on our way to achieving the UN sustainable development goal of screening at least 70% of eligible women in the community.

Program 3

Expenses: $16,161 Revenue: $0

Yemanja embarked on preparation for the initiation of a screening mammography study that aims to improve understanding of the breast abnormalities that could presage the development of breast cancer in these underserved populations. We completed the study protocol and informed consent document and obtained ethical approval for the University of Lagos research ethics board, in preparation for study initiation in 2023. We also engaged the partnership of both government-owned public and private diagnostic centers and trained the participating staff in the conduct of clinical research studies and data collection.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $10,010

Program Service Revenue $0

Investment Income $-47,380

Other Revenue $0

TOTAL REVENUE $-37,370

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $51,316

Other Expenses $51,428

TOTAL EXPENSES $51,428

Year-over-Year Comparison

	2022	2021	Change
Revenue	$-37,370	$73,359	-1.5%
Expenses	$51,428	$17,742	+1.9%
Net Income	$-88,798	$55,617	-2.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Oluwatoyin Shonukan	President	40	Officer Director	$0	$0	$0
Olujimi Akindele	Vice President	2	Officer Director	$0	$0	$0
Patrick Haslett	Secretary	1	Officer Director	$0	$0	$0
Philippe Samama	Director	1	Director	$0	$0	$0
Khandan Baradaran	Director	0.5	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$-37,370	$51,428	$321,621	$-88,798
2021	$73,359	$17,742	$433,178	$55,617
2020	$350,035	$35	$351,580	$350,000